HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Stock data | 2024 | Change |
---|---|---|
Price | $3.12 | N/A |
Market Cap | $82.15M | N/A |
Shares Outstanding | 26.33M | N/A |
Employees | 13.00 | N/A |